Evaluation of nutrition assessment parameters in the presence of human immunodeficiency virus infection

Nutrition in Clinical Practice

Volumn 19, Issue 4, 2004, Pages 330-339

  Earthman, Carrie P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; AMPRENAVIR PHOSPHATE; ANTIRETROVIRUS AGENT; ATAZANAVIR; COTRIMOXAZOLE; DAPSONE; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; ENFUVIRTIDE; FOLIC ACID; GANCICLOVIR; INDINAVIR; ISONIAZID; LAMIVUDINE; MAGNESIUM; MEGESTROL ACETATE; NELFINAVIR; NEVIRAPINE; NICOTINIC ACID; PYRIDOXINE; RITONAVIR; SAQUINAVIR; STAVUDINE; TENOFOVIR; TENOFOVIR DISOPROXIL; ZALCITABINE; ZIDOVUDINE;

ABDOMINAL PAIN; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANAMNESIS; ANEMIA; ANOREXIA; ANTHROPOMETRIC PARAMETERS; ANTHROPOMETRY; APPETITE DISORDER; BIOCHEMISTRY; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; DEHYDRATION; DIETARY INTAKE; DRUG INDUCED DISEASE; FATIGUE; GASTROINTESTINAL DISEASE; HEADACHE; HEPATITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; HYPERLIPIDEMIA; JAUNDICE; KIDNEY DISEASE; LIPODYSTROPHY; MALAISE; MALNUTRITION; METABOLIC DISORDER; METHODOLOGY; MORBIDITY; MORTALITY; MOUTH ULCER; MUSCLE WEAKNESS; NAUSEA; NEPHROLITHIASIS; NEUROPATHY; NUTRITION; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OBESITY; PANCREATITIS; PATIENT CARE; PHYSICAL EXAMINATION; PNEUMOCYSTIS PNEUMONIA; RASH; REVIEW; RISK FACTOR; SLEEP DISORDER; TASTE DISORDER; VOMITING; WASTING SYNDROME; WEIGHT REDUCTION;

HUMAN IMMUNODEFICIENCY VIRUS; PNEUMOCYSTIS CARINII;

EID: 3242732037     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0115426504019004330     Document Type: Review

References (55)

1. Nerad J, Romeyn M, Silverman E, et al. General nutrition management in patients infected with human immunodeficiency virus. Clin Infect Dis. 2003;36(Suppl):S52-S62.
2. Grinspoon S, Mulligan K. Weight loss and wasting in patients with human immunodeficiency virus. Clin Infect Dis. 2003;36(Suppl):S69-S78.
3. American Dietetic Association and Dietitians of Canada. Position of the American Dietetic Association and Dietitians of Canada: nutrition intervention in the care of persons with human immunodeficiency virus infection. J Am Diet Assoc. 2000;100:708-717.
4. Shevitz AH, Knox TA. Nutrition in the era of highly active antiretroviral therapy. Clin Infect Dis. 2001;32:1769-1775.
5. Polsky B, Kotler D, Steinhart C. HIV-associated wasting in the HAART era: guidelines for assessment, diagnosis, and treatment. AIDS Patient Care STD. 2001;15:411-423.
6. Mhiri C, Belec L, Di Costanza B, Georges A, Gherardi R. The slim disease in African patients with AIDS. Trans R Soc Trop Med Hyg. 1992;86:303-306.
7. Guenter P, Muurahaninen N, Simons G, et al. Relationships between nutritional status, disease progression, and survival in HIV infection. J Acquir Immune Defic Syndr. 1993;6:1130-1138.
8. Palenicek JP, Graham NM, He YD, et al. Multicenter AIDS Cohort Study Investigators: weight loss prior to clinical AIDS as a predictor of survival. J Acquir Immune Defic Sydr. 1995;10:366-373.
9. Kotler DP. Nutritional alterations associated with HIV infection. J Acquired Immune Defic Syndr. 2000;25(Suppl):S81-S87.
10. Kotler DP, Tierney AR, Wang J, Peirson RN Jr. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr. 1989;50:444-447.
11. Ott M, Lembcke B, Fischer H, et al. Early changes of body composition in human immunodeficiency virus-infected patients: tetrapolar body impedance analysis indicates significant malnutrition. Am J Clin Nutr. 1993;57:15-19.
12. Suttmann U, Ockenga J, Selberg O, Hoogestraat L, Deicher H, Muller MJ. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:239-246.
13. Council of State and Territorial Epidemiologists, AIDS Program, Center for Infectious Diseases. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 1987;36(Suppl 1):1S-15S.
14. Roubenoff R, Grinspoon S, Skolnik PR, et al. Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men. Am J Physiol Endocrinol Metab. 2002;283:E138-E145.
15. Wancke CA, Silva M, Knox TA, Forrester J, Speigelman D, Gorbach SL. Weight loss and wasting remain common complications in individuals with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis. 2000;31:803-805.
16. Wheeler DA, Gibert CL, Launer CA, et al. Weight loss as a predictor of survival and disease progression in HIV infection: Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:80-85.
17. Carr A, Emery S, Law M, Puls R, Lundgren JD, Powderly WG. An objective case definition of lipodystrophy in HIV-infected adults. Lancet. 2003;361:726-735.
18. McDermott AY, Shevitz A, Knox T, Moen K, Johansen D, Paton N. Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women. Am J Clin Nutr. 2001;74:679-686.
19. Knox TA, Zafonte-Sanders M, Fields-Gardner C, et al. Assessment of nutritional status, body composition, and human immunodeficiency virus-associated morphologic changes. Clin Infect Dis. 2003;36(Suppl):S63-S68.
20. Hadigan C, Meigs JB, Corcoran C, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis. 2001;32:130-139.
21. Lohman TG, Roche AF, Martorell R, eds. Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics; 1988.
22. Fields-Gardner C, Thomson CA, Rhodes SS. A Clinician's Guide to Nutrition in HIV and AIDS. Chicago, IL: The American Dietetic Association; 1997:18-42.
23. National Institutes of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute; 1998. NIH Publication No. 98-4083.
24. th ed. Chicago, IL: American Dietetic Association; 2000.
25. Howell WH. Anthropometry and body composition analysis. In: Matarese LE, Gottschlich MM, eds. Contemporary Nutrition Support Practice: A Clinical Guide. Philadelphia, PA: WB Saunders Company; 1998:33-46.
26. Earthman CP, Reid PM, Harper IT, Ravussin E, Howell WH. Body cell mass repletion and improved quality of life in HIV-infected individuals receiving oxandrolone. JPEN. 2002;26:357-365.
27. Shizgal HM. Nutritional assessment with body composition measurements by multiple isotope dilution. Infusionstherapie. 1990;17:9-17.
28. Moore FD, Boyden CM. Body cell mass and limits of hydration of the fat-free body: their relation to estimated skeletal weight. Ann N Y Acad Sci. 1963;110:62-71.
29. Grinspoon S. Measurement and clinical significance of body-composition changes in HIV disease. Nutrition. 2000;16:1102-1104.
30. Forbes GB. Human Body Composition. New York, NY: Springer Verlag, 1987.
31. James HM, Dabek JT, Chettle DR, et al. Whole body cellular and collagen nitrogen in healthy and wasted man. Clin Sci. 1984;67:73-82.
32. Beddoe AH, Streat SJ, Hill GL. Hydration of fat-free body in protein-depleted patients. Am J Physiol. 1985;249:E227-E233.
33. Foster KR, Lukaski HC. Whole-body impedance: what does it measure? Am J Clin Nutr. 1996;64(Suppl):388S-396S.
34. Heymsfield SB, Wang Z, Visser M, Gallagher D, Pierson RN. Techniques used in the measurement of body composition: an overview with emphasis on bioelectrical impedance analysis. Am J Clin Nutr. 1996;64(Suppl):478S-484S.
35. Cole KS. Membranes, Ions and Impulses: A Chapter of Classical Biophysics. Berkeley, CA: University of California Press; 1972.
36. De Lorenzo A, Andreoli A, Matthie J, Withers P. Predicting body cell mass with bioimpedance by using theoretical methods: a technological review. J Appl Physiol. 1997;82:1542-1558.
37. Sluys TE, van der Ende ME, Swart GR, van den Berg JW, Wilson JH. Body composition in patients with acquired immunodeficiency syndrome: a validation study of bioelectric impedance analysis. JPEN. 1993;17:404-406.
38. Kotler DP, Burastero S, Wang J, Pierson RN Jr. Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: effects of race, sex, and disease. Am J Clin Nutr. 1996;64(Suppl):489S-497S.
39. Kotler DP, Rosenbaum K, Allison DB, Wang J, Pierson RN. Validation of bioimpedance analysis as a measure of change in body cell mass as estimated by whole-body counting of potassium in adults. JPEN. 1999;23:345-349.
40. Jacobs DO. Use of biolectrical impedance analysis measurements in the clinical management of critical illness. Am J Clin Nutr. 1996;64(Suppl):498S- 502S.
41. Kotler DP, Wang J, Pierson RN. Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr. 1985;42:1255-1265.
42. Earthman CP, Matthie JR, Reid PM, Harper IT, Ravussin E, Howell WH. A comparison of bioimpedance methods for detection of body cell mass change in HIV infection. J Appl Physiol. 2000;88:944-956.
43. Corcoran C, Anderson EJ, Burrows B, et al. Comparison of total body potassium with other techniques for measuring lean body mass in men and women with AIDS wasting. Am J Clin Nutr. 2000;72:1053-1058.
44. Hadigan C, Corcoran C, Stanley T, Piecuch S, Klibanski A, Grinspoon S. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use. J Clin Endocrinol Metab. 2000;85:35-41.
45. nd edition. Philadelphia, PA: WB Saunders Company; 2003:45-62.
46. Salomon J, de Truchis P, Melchior J. Body composition and nutritional parameters in HIV and AIDS patients. Clin Chem Lab Med. 2002;40:1329-1333.
47. Baum MK, Shor-Posner G. Nutritional status and survival in HIV-1 disease. AIDS. 1997;11:689-690.
48. Patrick L. Nutrients and HIV: part two: vitamins A and E, zinc, B-vitamins, and magnesium. Alt Med Rev. 2000;5:39-51.
49. Geene D, Sudre P, Anwar D, Goehring C, Saaidia A, Hirschel B. Causes of macrocytosis in HIV-infected patients not treated with zidovudine: Swiss HIV Cohort Study. J Infect. 2000;40:160-163.
50. Remacha AF, Cadafalch J, Sarda P, Barcelo M, Fuster M. Vitamin B-12 metabolism in HIV-infected patients in the age of highly active antiretroviral therapy: role of homocysteine in assessing vitamin B-12 status. Am J Clin Nutr. 2003;77:420-424.
51. Woods MN, Tang AM, Forrester J, et al. Effect of dietary intake and protease inhibitors on serum vitamin B12 levels in a cohort of human immunodeficiency virus-positive patients. Clin Infect Dis. 2003;37(Suppl):S124- S131.
52. AIDSinfo [US Department of Health and Human Services Web site]. Available at: http://aidsinfo.nih.gov/drugs/. Accessed January 27, 2004.
53. Knox TA, Spiegelman D, Skinner SC, Gorbach S. Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection. Am J Gastroenterol. 2000;95:3482-3489.
54. Hammond K. History and physical examination. In: Matarese LE, Gottschlich MM, eds. Contemporary Nutrition Support Practice: A Clinical Guide. Philadelphia, PA: WB Saunders Company; 1998:17-32.
55. The American Dietetic Association. HIV/AIDS medical nutrition therapy protocol: medical nutrition therapy across the continuum of care. Chicago, IL: The American Dietetic Association; 1998.